School patents method using umbilical cord-blood cells

07/9/2010 | American City Business Journals

The University of South Florida's department of neurosurgery and brain repair has received a patent for a cell transplantation method that uses human umbilical cord-blood cells in combination with a compound called mannitol to treat neurodegenerative diseases. Saneron CCEL Therapeutics, a biotech research and development company, has licensed the technology.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA